Problem: Advancements in technology in the scientific arena have led to the requirement to store larger numbers of compounds including small molecules, potential drug candidates or biological samples.

Problem: The use of laboratory automation increases productivity and precision, making it attractive for use in the pharmaceutical industry.

Since the early 1990s, biobanking has been evolving as a key resource, increasing the availability and use of biological material such as DNA, RNA, tissues and cells for biomedical research.

It is essential for medicinal chemists to have access to analytical instrumentation for reaction monitoring and product analysis. However, due to the associated high capital cost and maintenance overheads, it is not possible to install and support instrumentation in every lab across a research site.

TTP LabTech has developed both bead- and cell-based fluorescence methods for the screening of antibodies against soluble and cell surface antigens.

The steadily escalating cost of the drug discovery process means companies are continuously looking for ways to increase process and cost efficiency.